Flow cytometry assessment of residual melanoma cells in tumor-infiltrating lymphocyte cultures
Article first published online: 29 MAR 2012
Copyright © 2012 International Society for Advancement of Cytometry
Cytometry Part A
Volume 81A, Issue 5, pages 374–381, May 2012
How to Cite
Richards, J. O., Treisman, J., Garlie, N., Hanson, J. P. and Oaks, M. K. (2012), Flow cytometry assessment of residual melanoma cells in tumor-infiltrating lymphocyte cultures. Cytometry, 81A: 374–381. doi: 10.1002/cyto.a.22047
- Issue published online: 19 APR 2012
- Article first published online: 29 MAR 2012
- Manuscript Accepted: 6 MAR 2012
- Manuscript Revised: 5 MAR 2012
- Manuscript Received: 14 NOV 2011
- Northwestern Mutual Foundation and Anne's Hope Foundation
- 1Cell therapy bioprocessing integrating process and product development for the next generation of biotherapeutics. Bioprocess Int 2011; 9: 30–37., , , , , .
- 7Guidance for FDA Reviews and Sponsors Content and Review of Chemistry, Manufacturing, and Control (CMC) Information for Human Somatic Cell Therapy Investigational New Drug Applications (INDs) United States Department of Health and Human Services FaDA. 2008.
- 16Detection of circulating tumor cells in breast cancer patients utilizing multiparameter flow cytometry and assessment of the prognosis of patients in different CTCs levels. Cytometry A 2010; 77A: 213–219., , , , , , , .
- 17Selecting reagents for multicolor flow cytometry with BDTM LSR II and BD FACSCantoTM systems. Nature Methods 2008; an6–an7., .